CRLX101 Plus Bevacizumab in Advanced RCC

Clinical trial NCT01625936 · COMPLETED

Trial details

NCT number: NCT01625936
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2012-06-01
Primary completion: 2017-07-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.